PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer - Wikidata - wikimedia - TriplyDB

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

http://www.wikidata.org/entity/Q28292541

about

Targeting androgen receptor in estrogen receptor-negative breast cancer The beta-catenin binding protein ICAT modulates androgen receptor activity Wnt/beta-catenin signaling and small molecule inhibitors Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate Cancer Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications Wnt/β-catenin signalling in prostate cancer Dysregulation of WNT/CTNNB1 and PI3K/AKT signaling in testicular stromal cells causes granulosa cell tumor of the testis Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival.BRAF activation initiates but does not maintain invasive prostate adenocarcinoma Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells.Inositol hexaphosphate suppresses growth and induces apoptosis in prostate carcinoma cells in culture and nude mouse xenograft: PI3K-Akt pathway as potential target.PTEN knockout prostate cancer as a model for experimental immunotherapy A genome-wide siRNA screen identifies novel phospho-enzymes affecting Wnt/β-catenin signaling in mouse embryonic stem cells.Molecular genetics of prostate cancer: new prospects for old challenges Slug inhibits proliferation of human prostate cancer cells via downregulation of cyclin D1 expression.GSK3β-dependent phosphorylation alters DNA binding, transactivity and half-life of the transcription factor USF2.Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress.Abiraterone acetate: a promising drug for the treatment of castration-resistant prostate cancer.Suppression of cholangiocarcinoma cell growth by human umbilical cord mesenchymal stem cells: a possible role of Wnt and Akt signaling.Loss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/β-catenin signaling Development of a peptide-drug conjugate for prostate cancer therapy.The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers.Presenilins regulate the cellular level of the tumor suppressor PTEN.The transcription factor ERG increases expression of neurotransmitter receptors on prostate cancer cells.Tyrosine-phosphorylated galectin-3 protein is resistant to prostate-specific antigen (PSA) cleavage Decreased spermatogenesis, fertility, and altered Slc2A expression in Akt1-/- and Akt2-/- testes and sperm.MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis SOX4 Is Essential for Prostate Tumorigenesis Initiated by PTEN Ablation.Inhibition of Akt pathways in the treatment of prostate cancer.Perifosine induces differentiation and cell death in prostate cancer cells Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells Synergistic effects of Pten loss and WNT/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression.Portrait of PTEN: messages from mutant mice.Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor Activity Sinularin Induces Apoptosis through Mitochondria Dysfunction and Inactivation of the pI3K/Akt/mTOR Pathway in Gastric Carcinoma Cells.Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1.

P2860

Q24312457-A75FBED8-C14B-40E9-AF07-2D583FB47AA1 Q24337124-8C784857-26C0-44B6-861D-09817F286BA0 Q24597197-9801E9AB-D44A-44D8-B47B-01BB5553A16B Q24685475-84C874F8-A1E2-4738-A864-F64103387DBF Q26768475-791B54C9-72EB-42D2-B5CD-CE3F1F219D7A Q26774902-3D291F7E-A29D-4CDD-89DD-D10259A4807E Q26863333-F2D9526E-2DBF-4F5A-B10F-32FA925672E1 Q28076060-E6146D33-8B58-4BE2-AF47-78B4DA63A05F Q28269116-9CDE8F72-A9BF-4EA1-BAAA-41FED2C24316 Q30436220-DF53A857-F977-4554-876C-BB234F0DF83C Q33387448-30FBB183-874D-44DF-AB12-6C081FF3220E Q33392719-204E6600-861F-43BF-9DE3-0274D5BC58B4 Q33433522-CEB5B97D-CC6E-44E2-81B5-9D512D7C0F52 Q33644080-A9C8320E-DF7B-4B15-AB20-181D52A4C00E Q33728431-4254CCEF-B4C6-4062-A332-D138BEBE8763 Q33873840-8E2F5E28-8CCC-486D-817C-16FD5C849CC4 Q34127462-65DD5568-430B-4ECC-8C07-98BA115AAB26 Q34148084-EE1E8012-6863-4729-8BF2-048BE83476A5 Q34216085-DEE4B886-6EFB-454D-AE26-8DEC7A3AC2E2 Q34528331-7C9DECC8-E112-4260-8372-22B7512F20B4 Q34619574-1C5E58DD-FB1D-4C7D-91BC-F7C9D0123FC8 Q34706869-2AB6FC72-C186-454D-A302-F7BC7DD2439C Q34803102-CE94E8C2-CA82-48FC-849E-391915F91087 Q35184864-36A50FF5-8C4B-40CA-9EA1-FA3D8C833D42 Q35214708-ED387F01-7755-4C6D-94CC-05BB450E3657 Q35510445-5101C7E1-9DDD-40C1-B906-3595838DDB14 Q35511420-0991B035-9EBB-4D5E-8BE5-860901CF2A87 Q35756563-4BF7F795-5916-4C7A-82C0-EC15BA289139 Q35773875-887BE40F-183E-4497-B75E-BB9683096A90 Q35931063-F0717C75-ABB7-44E5-97B9-BE12388D56DC Q36580396-757F7235-BA9B-4BDD-9391-71223215CD06 Q36655495-73AD84A5-AFA6-42B1-85A3-0A6F84E17AA9 Q36807494-EC7F9D8F-1396-4C42-A69E-6F2A7BB7D1D0 Q36852440-FC87F632-0551-4A0E-B4E8-AF016E5C4C86 Q36924212-1BE1D450-964C-4D8B-B91D-1059637C1C86 Q36959003-1D736B58-DFD9-488D-A068-B3FC640DB986 Q37059129-B091BCB2-6219-415E-A189-AD4821F7FEEA Q37066598-168ACBC0-6A35-4987-B510-BD48CA0884D5 Q37209174-13ADD0E5-CA46-48BF-BB7F-B856BA00C25D Q37269294-794F5960-0D99-4FAA-BA1B-51453018556D

P2860

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

http://www.wikidata.org/entity/Q28292541

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

@ast

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

@en

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

@nl

type

label

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

@ast

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

@en

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

@nl

prefLabel

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

@ast

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

@en

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

@nl

P1433

Q28292541-E91D61B0-4E02-42C6-8B77-9D7EFE893074

P1476

Q28292541-332C4A2A-B55B-46FA-93A3-05C76C39C97A

P2093

Q28292541-0173820A-0D6E-43BA-8759-3AD91E5CCCEC

Q28292541-7CEE8F2E-94ED-4EE2-BFF2-7249E9EF2F8A

Q28292541-CF198297-F01A-4995-9E2F-5952BE78D647

P2860

Q28292541-00F110AD-C320-4CD7-863E-EE31C69D5DC5

Q28292541-0F63C193-F3D3-4A40-A763-AE7C43F65310

Q28292541-104430EC-5EBD-404D-88EE-FCACBF8E12FE

Q28292541-2543D5EB-913A-4701-BF10-6CA87081C822

Q28292541-4D756021-DDD1-4EF8-B717-7C83B3990975

Q28292541-57970DC1-26D6-4101-A652-0B0B6347CC47

Q28292541-660E66C1-260C-4548-B990-A4C2CE9801C8

Q28292541-67C33BA9-3D92-4B8E-9A55-6BAA03626616

Q28292541-6AB14DED-BAF5-4E98-B5B7-51E2F2B0D479

Q28292541-807A8047-4962-462F-B0B2-B84406F5FA6D

P2888

Q28292541-21F2EBB6-B7EA-47D7-B14A-512EDBEB7CC2

P304

Q28292541-D2F0B880-1D20-4FF7-93D7-6908D1172F7D

P31

Q28292541-6CFEF89A-048F-4EF9-9C71-0A95CC3488F8

P3181

Q28292541-DAA470F3-B7D9-42B5-A5D8-8A8DD25DC462

P356

Q28292541-57D1CC2D-E8D0-4D7B-AB41-ABE1EF27BFF6

P407

Q28292541-DDF50410-4FAB-41F6-92F8-603CF4BC27E0

P433

Q28292541-64D0DB5F-8C9E-4B61-B504-2765953CCF90

P478

Q28292541-ABEBB535-AF16-46A5-B71A-BFB5C134C17A

P50

Q28292541-73D3662A-FF58-42DD-AC18-AA4DD91608AC

P577

Q28292541-67A72750-7ED6-4E2E-8A22-CB6A17819EFB

P5875

Q28292541-F0048370-7C5D-4F13-B820-AC50FDB45CFB

P6179

Q28292541-A9093361-F185-48BE-AD12-CE428AF17DAF

P698

Q28292541-E5DA9E02-2147-4D73-93A7-1026CB7EBEF9

P3181

P356

P1433

P1476

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

@en

P2093

C C Nelson

http://www.w3.org/2001/XMLSchema#string

D J Mulholland

http://www.w3.org/2001/XMLSchema#string

H Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor

Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells

AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR.

GSK-3: tricks of the trade for a multi-tasking kinase

Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor

Allosteric activation of PTEN phosphatase by phosphatidylinositol 4,5-bisphosphate

Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis

Liganded androgen receptor interaction with beta-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells

P2888

P304

329-337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4279108

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.ONC.1209020

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7350195

http://www.w3.org/2001/XMLSchema#string

P6179

1016164983

http://www.w3.org/2001/XMLSchema#string

P698

16421604

http://www.w3.org/2001/XMLSchema#string